Samson, Susan L.

Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm - 2020 executive summary

Garber, A. J., Handelsman, Y., Grunberger, G., Einhorn, D., Abrahamson, M. J., Barzilay, J. I., Blonde, L., Bush, M. A., DeFronzo, R. A., Garber, J. R., et al. (2020) · Endocrine Practice

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 598

American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update.

Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 507

Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society International Consensus Statement

Petersenn, S., Fleseriu, M., Casanueva, F. F., Giustina, A., Biermasz, N., Biller, B. M. K., Bronstein, M., Chanson, P., Fukuoka, H., Gadelha, M., et al. (2023) · Nature Reviews Endocrinology

Pituitary Gland Disorders and TreatmentsNeuroendocrine Tumor Research Advances

Cited by 411

American Association of Clinical Endocrinology consensus statement: comprehensive type 2 diabetes management algorithm—2023 update

Samson, S. L., Vellanki, P., Blonde, L., Christofides, E. A., Galindo, R. J., Hirsch, I. B., Isaacs, S. D., Izuora, K. E., Low Wang, C. C., Twining, C. L., et al. (2023) · Endocrine Practice

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 375

Effects of combined exenatide and pioglitazone therapy on hepatic fat content in type 2 diabetes

Sathyanarayana, P., Jogi, M., Muthupillai, R., Krishnamurthy, R., Samson, S. L., & Bajaj, M. (2011) · Obesity

Diabetes Treatment and ManagementLiver Disease Diagnosis and Treatment

Cited by 124

Exenatide decreases hepatic fibroblast growth factor 21 resistance in non-alcoholic fatty liver disease in a mouse model of obesity and in a randomised controlled trial

Samson, S. L., Sathyanarayana, P., Jogi, M., Gonzalez, E. V., Gutierrez, A., Krishnamurthy, R., Muthupillai, R., Chan, L., & Bajaj, M. (2011) · Diabetologia

Fibroblast Growth Factor ResearchLiver Disease Diagnosis and Treatment

Cited by 110

American Association of Clinical Endocrinologists and American College of Endocrinology Disease State Clinical Review: Update on Growth Hormone Stimulation Testing and Proposed Revised Cut-Point for the Glucagon Stimulation Test in the Diagnosis Of Adult Growth Hormone Deficiency

Yuen, K. C. J., Tritos, N. A., Samson, S. L., Hoffman, A. R., & Katznelson, L. (2016) · Endocrine Practice

Growth Hormone and Insulin-like Growth FactorsPituitary Gland Disorders and Treatments

Cited by 73

GLP-1R agonist therapy for diabetes: benefits and potential risks

Samson, S. L., & Garber, A. (2013) · Current Opinion in Endocrinology, Diabetes & Obesity

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 55

Gene therapy for diabetes: Metabolic effects of helper-dependent adenoviral exendin 4 expression in a diet-induced obesity mouse model

Samson, S. L., Gonzalez, E. V., Yechoor, V., Bajaj, M., Oka, K., & Chan, L. (2008) · Molecular Therapy

Virus-based gene therapy researchDiabetes Treatment and Management

Cited by 54